These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10617896)

  • 81. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.
    Potters L; Cao Y; Calugaru E; Torre T; Fearn P; Wang XH
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):605-14. PubMed ID: 11395226
    [TBL] [Abstract][Full Text] [Related]  

  • 82. 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma.
    Dattoli M; Wallner K; Sorace R; Koval J; Cash J; Acosta R; Brown C; Etheridge J; Binder M; Brunelle R; Kirwan N; Sanchez S; Stein D; Wasserman S
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):875-9. PubMed ID: 8751395
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [I125 low dose rate brachytherapy in localized prostate cancer. Preliminary results after 5 years].
    Prada PJ; Hevia M; Juan G; Abascal JM; de la Rúa A; Abascal R; Fernández J; Rodríguez R
    Arch Esp Urol; 2005 Apr; 58(3):213-26; discussion 224. PubMed ID: 15906615
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer.
    Sharkey J; Cantor A; Solc Z; Huff W; Chovnick SD; Behar RJ; Perez R; Otheguy J; Rabinowitz R
    Curr Urol Rep; 2002 Jun; 3(3):250-7. PubMed ID: 12084197
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Secondary bladder cancer during long-term follow-up after iodine-125 permanent seed implantation for localized prostate cancer.
    Ozawa Y; Yagi Y; Nakamura K; Hattori S; Nishiyama T; Momma T; Yorozu A; Saito S
    Brachytherapy; 2022; 21(4):451-459. PubMed ID: 35461773
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience.
    Korb LJ; Brawer MK
    Rev Urol; 2001; 3(1):51-62. PubMed ID: 16985691
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Improved outcomes with radiation for prostate cancer.
    Wallner K
    Hematol Oncol Clin North Am; 2001 Apr; 15(2):359-75. PubMed ID: 11370498
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Cancer J; 2002; 8(1):79-80. PubMed ID: 11895207
    [No Abstract]   [Full Text] [Related]  

  • 89. Authors' response.
    Kahn JM; Moghanaki D
    Brachytherapy; 2020; 19(4):555. PubMed ID: 32674913
    [No Abstract]   [Full Text] [Related]  

  • 90. Brachytherapy as a treatment option for prostate cancer: overview and nursing considerations.
    Brumm J
    Proc (Bayl Univ Med Cent); 2000 Jul; 13(3):227-9. PubMed ID: 16389386
    [No Abstract]   [Full Text] [Related]  

  • 91. Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
    Slawin KM; Diblasio CJ; Kattan MW
    Rev Urol; 2004; 6 Suppl 4(Suppl 4):S3-8. PubMed ID: 16985868
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation.
    Stokes SH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):129-36. PubMed ID: 10758314
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
    Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS
    Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Does brachytherapy have a role in the treatment of prostate cancer?
    Grimm PD; Blasko JC; Ragde H; Sylvester J; Clarke D
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):653-73. PubMed ID: 8773503
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Brachytherapy for clinically localized prostate cancer.
    Ragde H; Korb L
    Semin Surg Oncol; 2000; 18(1):45-51. PubMed ID: 10617896
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma.
    Ragde H; Elgamal AA; Snow PB; Brandt J; Bartolucci AA; Nadir BS; Korb LJ
    Cancer; 1998 Sep; 83(5):989-1001. PubMed ID: 9731904
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.